AusBiotech

TGA head 'impressed' with COVID-19 vaccine efficacy December 3, 2020

TGA head John Skerritt has confirmed the government is "hopeful" the first COVID-19 vaccines will be "rolled-out" to Australians at the end of the first quarter next year.

Rhythm Biosciences appoints French company to manufacture ColoSTAT test-kit December 3, 2020

Rhythm Biosciences (ASX: RHY) has appointed French company Biotem as the global manufacturer of its ColoSTAT test-kit.

FDA grants fast-track designation to Mesoblast treatement December 3, 2020

The US FDA has granted fast-track designation to Mesoblast's (ASX:MSB) remestemcel-L in the treatment of acute respiratory distress syndrome (ARDS) due to COVID-19 infection.

Noxopharm completes $23m share placement December 3, 2020

Australian clinical-stage drug development company Noxopharm (ASX:NOX) has completed a $23 million share placement to professional, institutional, and sophisticated investors.

Global manufacturing survey invites Australia’s views December 3, 2020

Australian manufacturers invited to contribute to global benchmarking, with the 18th Annual Biopharmaceutical Manufacturing global survey underway.

UK repurposing sports stadiums as mass vaccination centres December 3, 2020

The UK is preparing to launch its COVID-19 immunisation program next week and is planning to eventually use repurposed sporting stadiums as mass immunisation centres.

Telix Pharmaceuticals acquires Swiss-German counterpart December 1, 2020

Australian biotechnology company Telix Pharmaceuticals has announced it will acquire Swiss-German counterpart TheraPharm for its portfolio of potential diagnostics and treatments for haematological diseases like blood cancer.

Dimerix announces a new COVID-19 study for DMX-200 December 1, 2020

Clinical-stage company Dimerix (ASX:DXB) has announced its lead candidate DMX-200 will enter a second clinical study in COVID-19 patients.

Australian invention deployed as first instant patient isolation room December 1, 2020

An Australian invention has become the world's first deployed hospital instant patient isolation room to support the health response to COVID-19.

AusBiotech showcases Australia’s clinical trials advantages during JP Morgan December 1, 2020

AusBiotech is set to showcase the globally-recognised strength of the Australian clinical trials sector during JP Morgan week in January 2021.

Sydney research discovery could lead to new cancer therapies December 1, 2020

Researchers at Children’s Medical Research Institute (CMRI) in Westmead, Sydney, say they have made an unexpected discovery about cancer cells.

TGA registration for Rhinomed's new nasal swab November 26, 2020

Nasal airway and respiratory technology company Rhinomed (ASX:RNO) has announced the TGA has registered its high load capturing nasal swab as a Class 1 device.

Most Read

TGA head 'impressed' with COVID-19 vaccine efficacy

Noxopharm completes $23m share placement

Global manufacturing survey invites Australia’s views

FDA grants fast-track designation to Mesoblast treatement

UK repurposing sports stadiums as mass vaccination centres

New Stories

TGA head 'impressed' with COVID-19 vaccine efficacy

Rhythm Biosciences appoints French company to manufacture ColoSTAT test-kit

FDA grants fast-track designation to Mesoblast treatement

Noxopharm completes $23m share placement

Global manufacturing survey invites Australia’s views

UK repurposing sports stadiums as mass vaccination centres

Telix Pharmaceuticals acquires Swiss-German counterpart

Sign In

Most Read

TGA head 'impressed' with COVID-19 vaccine efficacy

Noxopharm completes $23m share placement

Global manufacturing survey invites Australia’s views

FDA grants fast-track designation to Mesoblast treatement

UK repurposing sports stadiums as mass vaccination centres

Follow Us

New Stories

TGA head 'impressed' with COVID-19 vaccine efficacy

Rhythm Biosciences appoints French company to manufacture ColoSTAT test-kit

FDA grants fast-track designation to Mesoblast treatement

Noxopharm completes $23m share placement

Global manufacturing survey invites Australia’s views

UK repurposing sports stadiums as mass vaccination centres

Telix Pharmaceuticals acquires Swiss-German counterpart